Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Bryostatin 1 in Ovarian Cancer Administered by Weekly 24 Hour Intravenous Infusion

NCT00004008 is registered in ClinicalTrials.gov with University of Glasgow as lead sponsor.

NCT NCT00004008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Bryostatin 1 in Ovarian Cancer Administered by Weekly 24 Hour Intravenous Infusion
Lead sponsor
University of Glasgow
Phase
Phase 2
Overall status
Completed
Start date
July 31, 1999
Completion date
May 31, 2003
Enrollment
Not reported
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer